000 01353 a2200409 4500
005 20250511152620.0
264 0 _c19761101
008 197611s 0 0 eng d
022 _a0014-2999
024 7 _a10.1016/0014-2999(76)90034-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRoba, J
245 0 0 _aAntiplatelet and antithrombogenic effects of suloctidil.
_h[electronic resource]
260 _bEuropean journal of pharmacology
_cJun 1976
300 _a265-74 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdenosine Diphosphate
_xantagonists & inhibitors
650 0 4 _aAnimals
650 0 4 _aAspirin
_xpharmacology
650 0 4 _aBlood Pressure
_xdrug effects
650 0 4 _aDogs
650 0 4 _aFemale
650 0 4 _aFibrinolytic Agents
_xpharmacology
650 0 4 _aHaplorhini
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMice, Inbred Strains
650 0 4 _aPlatelet Aggregation
_xdrug effects
650 0 4 _aPropanolamines
_xpharmacology
650 0 4 _aRats
650 0 4 _aThrombophlebitis
_xprevention & control
650 0 4 _aThrombosis
_xprevention & control
700 1 _aClaeys, M
700 1 _aLambelin, G
773 0 _tEuropean journal of pharmacology
_gvol. 37
_gno. 2
_gp. 265-74
856 4 0 _uhttps://doi.org/10.1016/0014-2999(76)90034-0
_zAvailable from publisher's website
999 _c829703
_d829703